Literature DB >> 2397747

Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist.

P A Martorana1, B Kettenbach, G Breipohl, W Linz, B A Schölkens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2397747     DOI： 10.1016/0014-2999(90)90301-l

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  17 in total

1.  Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors?

Authors:  P A Martorana; W Linz; B A Schölkens
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

Review 2.  The role of kinins in the antihypertensive and cardioprotective effects of ACE inhibitors.

Authors:  G Bönner
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 3.  The renin-angiotensin-aldosterone system and cardiac ischaemia.

Authors:  H Ikram
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

4.  The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.

Authors:  M A Rastegar; F Marchini; G Morazzoni; A Vegh; J G Papp; J R Parratt
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Insights from animal models of myocardial infarction: do ACE inhibitors limit the structural response?

Authors:  J F Smits; M J Daemen
Journal:  Br Heart J       Date:  1994-09

6.  Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.

Authors:  V Richard; B Ghaleh; A Berdeaux; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

7.  Delineation of a region in the B2 bradykinin receptor that is essential for high-affinity agonist binding.

Authors:  J Nardone; P G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

Review 8.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

9.  Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs.

Authors:  A Vegh; L Szekeres; J R Parratt
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

10.  Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.

Authors:  A Vegh; L Szekeres; J Parratt
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.